English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, July 4, 2025
Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation
雲頂新耀發佈AI+mRNA平台新突破 重塑中國mRNA國際競爭格局
云顶新耀发布AI+mRNA平台新突破 重塑中国mRNA国际竞争格局
Thursday, July 3, 2025
雲頂新耀公佈EVER001-1b/2a期階段性數據 專家看好其作為新一代BTK療法的潛力
云顶新耀公布EVER001-1b/2a期阶段性数据 专家看好其作为新一代BTK疗法的潜力
Friday, June 20, 2025
雲頂新耀加速全球佈局 耐賦康(R)與EVER001雙引擎釋放創新藥價值潛力
云顶新耀加速全球布局 耐赋康(R)与EVER001双引擎释放创新药价值潜力
Thursday, June 12, 2025
NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances
耐賦康(R)與EVER001協同發力 雲頂新耀推動腎病治療進入精準管理新階段
耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575